Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christopher Grilli

Vascular & Interventional Radiology Newark, DE Medical Doctor

NPI 1134395445 CMS profile 822539

4755 Ogletown - Stanton Road, Suite 1E-20, Newark, DE 19718

Open in the dashboard

General payments

$93,018

337 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$49,953 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Christopher Grilli of Newark, DE is reported in the CMS Open Payments database as having received $93,018 across 337 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $49,953 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $41,584 83
2024 General $30,489 81
2023 General $3,316 49
2022 General $4,423 40
2021 General $4,075 22
2020 General $7,862 19
2019 General $1,268 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Grilli
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Christopher Grilli were reported at $41,584. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Christopher Grilli Vascular & Interventional Radiology median Middle half National median
2019 $1,268 $422 $125–$1,555 $163
2020 $7,862 $200 $68–$652 $114
2021 $4,075 $280 $99–$866 $132
2022 $4,423 $433 $137–$1,497 $149
2023 $3,316 $506 $152–$2,019 $160
2024 $30,489 $556 $175–$1,930 $164
2025 $41,584 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $87,419 235 payments
  2. Penumbra, Inc. $1,277 12 payments
  3. Balt USA, LLC $1,263 17 payments
  4. Bard Peripheral Vascular, Inc. $842 7 payments
  5. Cagent Vascular LLC $505 2 payments
  6. Sirtex Medical Inc $287 12 payments
  7. Inari Medical, Inc. $176 4 payments
  8. Triad Life Sciences Inc. $146 4 payments
  9. Stryker Corporation $123 4 payments
  10. Janssen Pharmaceuticals, Inc $113 7 payments
  11. Other $867 33 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $45,097 22 payments
  2. Consulting Fee $27,975 10 payments
  3. Food and Beverage $11,658 273 payments
  4. Travel and Lodging $8,288 32 payments
Products named General payments · program years 2019–2025
  1. General - Embolics $28,989 22 payments
  2. EMBOLD Fibered $13,241 17 payments
  3. General - Therapies General - Therapies_PI $10,744 13 payments
  4. GENERAL - IO ABLATION $4,500 1 payment
  5. General - Vascular Intervention $3,376 5 payments
  6. General - Therapies Therapies $3,000 1 payment
  7. OBSIDIO $1,345 7 payments
  8. Indigo System $882 9 payments
  9. TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) $874 3 payments
  10. Prestige Coil System $783 9 payments
  11. Other $7,274 203 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

15

Median for Diagnostic Radiology: 24

Drug cost

$644

Median for Diagnostic Radiology: $190

Branded share of claims

0%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Solifenacin Succinate Generic 15 $644

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 116 billing codes

Paid by Medicare

$76,768

Medicare's payments for the services billed

Medicare patients

794

Average age 74

Services billed

1,270

429 women, 365 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 56%
Chronic kidney disease 44%
Ischemic heart disease 43%
Diabetes 41%
Heart failure 36%
Depression 35%
Atrial fibrillation 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

337 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record